Latest News 10th Heidelberg Laureate Forum to visit BioQuant on September 27th, 2023 September 27th, 2023 10th Heidelberg Laureate Forum to visit BioQuant on September 27th, 2023 BioQuant is proud to be one of the institutions visited by young scientists of the HLF. ERC Synergy Grant for studying the renewability and differentiation of stem cells in the vertebrate brain August 15th, 2023 ERC Synergy Grant for studying the renewability and differentiation of stem cells in the vertebrate brain Simon Anders (BioQuant) together with Anna Marciniak-Czochra (IWR), Ana Martin-Villalba (DKFZ) and Laure Bally-Cuif (Institut Pasteur in Paris) received an ERC Synergy Grant. Luring the Virus into a Trap April 26th, 2023 Luring the Virus into a Trap BioQuant Researchers from Chlanda and Schwarz Lab elucidate mechanisms that contribute to the prevention of Influenza A and Ebola virus infections. Gold again for Heidelberg in iGEM competition February 01st, 2023 Gold again for Heidelberg in iGEM competition The iGEM Team Heidelberg 2022 succeeded in winning another gold medal at the Grand Jamboree in Paris with their project "Hersiran: siRNA-Tech for Neuroinfections". iGEM is the world's largest competition for synthetic biology. MINFLUX nanoscope is now available at BioQuant allowing resolution of up to 2nm in 3D December 01st, 2022 MINFLUX nanoscope is now available at BioQuant allowing resolution of up to 2nm in 3D With the help of the Cellnetworks Core Technology Platform and its community, Heidelberg University recently received funding for a MINFLUX system via the REACT-EU programme of the European Union and the state of Baden-Württemberg. Next-generation bioengineered viruses for muscle gene therapy September 23rd, 2022 Next-generation bioengineered viruses for muscle gene therapy In a new publication, the BioQuant group of Prof. Dirk Grimm reports a novel generation of bioengineered Adeno-associated viruses (AAV) that hold exceptional promise for use in human gene therapy of muscle disorders. SARS-CoV-2 suppression with novel combinatorial AAV-RNAi vectors May 04th, 2022 SARS-CoV-2 suppression with novel combinatorial AAV-RNAi vectors Grimm Lab and collaborators at CIID present new recombinant AAV vectors, which inhibit coronavirus infection ex vivo and in vivo. All living cells possess a universal chemical mechanism for methane formation March 09th, 2022 All living cells possess a universal chemical mechanism for methane formation Bacillus subtilis releases methane. Surprised? Your body cells also release the greenhouse gas! Publication by Ilka Bischofs' Lab in Legal expert Prof. Dr. Fruzsina Molnár-Gábor appointed to the European Ethics Council February 21st, 2022 Legal expert Prof. Dr. Fruzsina Molnár-Gábor appointed to the European Ethics Council She joins the EU Commission’s advisory body advising on ethical questions posed by scientific and technological innovations
10th Heidelberg Laureate Forum to visit BioQuant on September 27th, 2023 September 27th, 2023 10th Heidelberg Laureate Forum to visit BioQuant on September 27th, 2023 BioQuant is proud to be one of the institutions visited by young scientists of the HLF.
ERC Synergy Grant for studying the renewability and differentiation of stem cells in the vertebrate brain August 15th, 2023 ERC Synergy Grant for studying the renewability and differentiation of stem cells in the vertebrate brain Simon Anders (BioQuant) together with Anna Marciniak-Czochra (IWR), Ana Martin-Villalba (DKFZ) and Laure Bally-Cuif (Institut Pasteur in Paris) received an ERC Synergy Grant.
Luring the Virus into a Trap April 26th, 2023 Luring the Virus into a Trap BioQuant Researchers from Chlanda and Schwarz Lab elucidate mechanisms that contribute to the prevention of Influenza A and Ebola virus infections.
Gold again for Heidelberg in iGEM competition February 01st, 2023 Gold again for Heidelberg in iGEM competition The iGEM Team Heidelberg 2022 succeeded in winning another gold medal at the Grand Jamboree in Paris with their project "Hersiran: siRNA-Tech for Neuroinfections". iGEM is the world's largest competition for synthetic biology.
MINFLUX nanoscope is now available at BioQuant allowing resolution of up to 2nm in 3D December 01st, 2022 MINFLUX nanoscope is now available at BioQuant allowing resolution of up to 2nm in 3D With the help of the Cellnetworks Core Technology Platform and its community, Heidelberg University recently received funding for a MINFLUX system via the REACT-EU programme of the European Union and the state of Baden-Württemberg.
Next-generation bioengineered viruses for muscle gene therapy September 23rd, 2022 Next-generation bioengineered viruses for muscle gene therapy In a new publication, the BioQuant group of Prof. Dirk Grimm reports a novel generation of bioengineered Adeno-associated viruses (AAV) that hold exceptional promise for use in human gene therapy of muscle disorders.
SARS-CoV-2 suppression with novel combinatorial AAV-RNAi vectors May 04th, 2022 SARS-CoV-2 suppression with novel combinatorial AAV-RNAi vectors Grimm Lab and collaborators at CIID present new recombinant AAV vectors, which inhibit coronavirus infection ex vivo and in vivo.
All living cells possess a universal chemical mechanism for methane formation March 09th, 2022 All living cells possess a universal chemical mechanism for methane formation Bacillus subtilis releases methane. Surprised? Your body cells also release the greenhouse gas! Publication by Ilka Bischofs' Lab in
Legal expert Prof. Dr. Fruzsina Molnár-Gábor appointed to the European Ethics Council February 21st, 2022 Legal expert Prof. Dr. Fruzsina Molnár-Gábor appointed to the European Ethics Council She joins the EU Commission’s advisory body advising on ethical questions posed by scientific and technological innovations